USAID Grants USD120 Million to New Anti-TB Treatments

The U.S. Agency for International Development will grant some USD120 million to boost global efforts to combat tuberculosis. Of the amount, around USD80 million will be awarded to the International Union Against TB and Lung Disease over a five-year period to help transform TB research results into global and national policies. The rest will be given to the Global Alliance for TB Drug Development also over five years to develop new medications that can decrease the duration of TB treatment, respond to drug-resistant TB and be safely administered with anti-retrovirals to HIV-infected people. (“USAID Awards Grants for Development of New Tuberculosis Drugs, Diagnostics, and Management Approaches” - U.S. Agency for International Development, Oct. 14, 2008)

About the author